Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
12.36
-0.09 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
12.35
-0.01 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pliant Therapeutics Revenue
Pliant Therapeutics had revenue of $248.00K in the twelve months ending March 31, 2024. In the year 2023, Pliant Therapeutics had annual revenue of $1.58M.
Revenue (ttm)
$248.00K
Revenue Growth
-97.46%
P/S Ratio
3,006.56
Revenue / Employee
$1,570
Employees
158
Market Cap
745.63M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
Dec 31, 2020 | 41.82M | -15.24M | -26.70% |
Dec 31, 2019 | 57.05M | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Embecta | 1.13B |
Phibro Animal Health | 999.56M |
Evolus | 219.70M |
Travere Therapeutics | 183.23M |
Sage Therapeutics | 91.06M |
4D Molecular Therapeutics | 20.45M |
PLRX News
- 5 weeks ago - Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors - GlobeNewsWire
- 5 weeks ago - Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™ - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™ - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Pliant Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire